Merus N.V. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ACRV
|
Acrivon Therapeutics, Inc. Common Stock | $7.76 | $223.86 M | -2.51 | 58 | $0 |
 ADAG
|
Adagene Inc. | $3.02 | $131.46 M | -6.77 | 174 | $18.11 M |
 ANAB
|
AnaptysBio, Inc. | $19.44 | $640.07 M | -3.82 | 117 | $17.16 M |
 ANEB
|
Anebulo Pharmaceuticals, Inc. | $1.88 | $56.28 M | -5.86 | 2 | $0 |
 CERE
|
Cerevel Therapeutics Holdings, Inc. | $44.96 | $7.29 B | -14.66 | 355 | $0 |
|
CRNX
|
Crinetics Pharmaceuticals, Inc. | $56.99 | $3.53 B | -11.86 | 290 | $4.01 M |
|
INBX
|
Inhibrx Biosciences, Inc. | $15.51 | $241.02 M | -1.44 | 166 | $1.80 M |
 KRON
|
Kronos Bio, Inc. | $0.95 | $44.62 M | -0.37 | 58 | $6.29 M |
 KURA
|
Kura Oncology, Inc. | $17.75 | $1.66 B | -10.03 | 142 | $0 |
 LRMR
|
Larimar Therapeutics, Inc. | $7.30 | $611.84 M | -9.99 | 42 | $0 |
 LYEL
|
Lyell Immunopharma, Inc. | $1.20 | $619.50 M | -2.7 | 224 | $130,000 |
|
MLYS
|
Mineralys Therapeutics, Inc. | $13.69 | $652.38 M | -6.03 | 28 | $0 |
 PCVX
|
Vaxcyte, Inc. | $106.40 | $7.72 B | -16.54 | 254 | $0 |
|
PTGX
|
Protagonist Therapeutics, Inc. | $44.76 | $2.04 B | 13.7 | 125 | $60.00 M |
 REPL
|
Replimune Group, Inc. | $11.93 | $485.18 M | -2.44 | 331 | $0 |
 SNDX
|
Syndax Pharmaceuticals, Inc. | $19.29 | $1.66 B | -6.02 | 184 | $0 |
|
STRO
|
Sutro Biopharma, Inc. | $3.68 | $303.46 M | -1.97 | 304 | $153.73 M |